China Drugs: A Cautionary Tale
A contaminated anticancer drug made by one of China's largest pharmaceutical companies underscores how quality-control problems continue to plague the Chinese drug industry. There is no sign the tainted leukemia drug was exported. But the case provides a cautionary tale as Western pharmaceutical companies start outsourcing some manufacturing to China.Last June, Yan Zhenni, a 5-year-old with leukemia from Shanghai, received a shot of the anticancer medication methotrexate. But the drug meant to treat her left her incontinent and unable to walk on her own, her mother says.
By NICHOLAS ZAMISKA and AVERY JOHNSON
31 January 2008